Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S4 from Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma
  1. Home
  2. Publications
  3. Table S4 from Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma

Table S4 from Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma

Authors:
  • GHGlenn J. Hanna
    Glenn J. Hanna
  • NSNicole Scarfo
    Nicole Scarfo
  • KSKee-Young Shin
    Kee-Young Shin
  • AOAnne O’nEill
    Anne O’nEill
  • VBVeronica Bedard
    Veronica Bedard
  • MDMichael J. Dennis
    Michael J. Dennis
  • KSKartik Sehgal
    Kartik Sehgal
  • VJVickie Y. Jo
    Vickie Y. Jo
  • KWKristine Wong
    Kristine Wong
  • AUAndrey Ugolkov
    Andrey Ugolkov
  • AMAndrew Mazar
    Andrew Mazar
  • RHRobert I. Haddad
    Robert I. Haddad

Open Access
Publisher website
Google Scholar
  • 6 January 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.31006830
Abstract
Predictors of overall survival (univariate cox proportional hazards model)
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • HEAD, NECK & ORAL CANCERS
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.